{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:07:17Z","timestamp":1787843237631,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03373-9","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T22:21:11Z","timestamp":1744496471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation of peripheral olfactomedin 1 with Alzheimer\u2019s disease and cognitive functions"],"prefix":"10.1038","volume":"15","author":[{"given":"Chunxiao","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-4653","authenticated-orcid":false,"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"3373_CR1","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19:1598\u2013695. https:\/\/doi.org\/10.1002\/alz.13016.","DOI":"10.1002\/alz.13016"},{"key":"3373_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"3373_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"key":"3373_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/35008643","volume":"2","author":"M Barembaum","year":"2000","unstructured":"Barembaum M, Moreno TA, LaBonne C, Sechrist J, Bronner-Fraser M. Noelin-1 is a secreted glycoprotein involved in generation of the neural crest. Nat Cell Biol. 2000;2:219\u201325. https:\/\/doi.org\/10.1038\/35008643","journal-title":"Nat Cell Biol"},{"key":"3373_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0169-328x(97)00271-4","volume":"53","author":"T Nagano","year":"1998","unstructured":"Nagano T, Nakamura A, Mori Y, Maeda M, Takami T, Shiosaka S, et al. Differentially expressed olfactomedin-related glycoproteins (Pancortins) in the brain. Brain Res Mol Brain Res. 1998;53:13\u201323. https:\/\/doi.org\/10.1016\/s0169-328x(97)00271-4","journal-title":"Brain Res Mol Brain Res"},{"key":"3373_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.psychres.2014.12.028","volume":"225","author":"B Bertelsen","year":"2015","unstructured":"Bertelsen B, Melchior L, Jensen LR, Groth C, Nazaryan L, Debes NM, et al. A t(3;9)(q25.1;q34.3) translocation leading to OLFM1 fusion transcripts in Gilles de la Tourette syndrome, OCD and ADHD. Psychiatry Res. 2015;225:268\u201375. https:\/\/doi.org\/10.1016\/j.psychres.2014.12.028","journal-title":"Psychiatry Res"},{"key":"3373_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/acs.jproteome.6b00659","volume":"16","author":"AC Kroksveen","year":"2017","unstructured":"Kroksveen AC, Guldbrandsen A, Vaudel M, Lereim RR, Barsnes H, Myhr KM, et al. In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis: presenting a comprehensive picture of pathways and processes affected by multiple sclerosis. J Proteome Res. 2017;16:179\u201394. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00659","journal-title":"J Proteome Res"},{"key":"3373_CR8","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41380-021-01061-w","volume":"26","author":"H Le-Niculescu","year":"2021","unstructured":"Le-Niculescu H, Roseberry K, Gill SS, Levey DF, Phalen PL, Mullen J, et al. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2021;26:2776\u2013804. https:\/\/doi.org\/10.1038\/s41380-021-01061-w","journal-title":"Mol Psychiatry"},{"key":"3373_CR9","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1242\/dev.082909","volume":"139","author":"HC Rice","year":"2012","unstructured":"Rice HC, Townsend M, Bai J, Suth S, Cavanaugh W, Selkoe DJ, et al. Pancortins interact with amyloid precursor protein and modulate cortical cell migration. Development. 2012;139:3986\u201396. https:\/\/doi.org\/10.1242\/dev.082909","journal-title":"Development"},{"key":"3373_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/jnc.14231","volume":"143","author":"N Nakaya","year":"2017","unstructured":"Nakaya N, Sultana A, Tomarev SI. Impaired AMPA receptor trafficking by a double knockout of zebrafish olfactomedin1a\/b. J Neurochem. 2017;143:635\u201344. https:\/\/doi.org\/10.1111\/jnc.14231","journal-title":"J Neurochem"},{"key":"3373_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.celrep.2018.06.102","volume":"24","author":"NJ Pandya","year":"2018","unstructured":"Pandya NJ, Seeger C, Babai N, Gonzalez-Lozano MA, Mack V, Lodder JC, et al. Noelin1 affects lateral mobility of synaptic AMPA receptors. Cell Rep. 2018;24:1218\u201330. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.102","journal-title":"Cell Rep"},{"key":"3373_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2016.07.041","volume":"166","author":"KH Loh","year":"2016","unstructured":"Loh KH, Stawski PS, Draycott AS, Udeshi ND, Lehrman EK, Wilton DK, et al. Proteomic analysis of unbounded cellular compartments: synaptic Clefts. Cell. 2016;166:1295\u2013307.e21. https:\/\/doi.org\/10.1016\/j.cell.2016.07.041","journal-title":"Cell"},{"key":"3373_CR13","doi-asserted-by":"publisher","first-page":"37171","DOI":"10.1074\/jbc.M112.389916","volume":"287","author":"N Nakaya","year":"2012","unstructured":"Nakaya N, Sultana A, Lee HS, Tomarev SI. Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth. J Biol Chem. 2012;287:37171\u201384. https:\/\/doi.org\/10.1074\/jbc.M112.389916","journal-title":"J Biol Chem"},{"key":"3373_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/wnl.39.3.355","volume":"39","author":"JE Hamos","year":"1989","unstructured":"Hamos JE, DeGennaro LJ, Drachman DA. Synaptic loss in Alzheimer\u2019s disease and other dementias. Neurology. 1989;39:355\u201361. https:\/\/doi.org\/10.1212\/wnl.39.3.355","journal-title":"Neurology"},{"key":"3373_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","volume":"139","author":"J Griffiths","year":"2023","unstructured":"Griffiths J, Grant SGN. Synapse pathology in Alzheimer\u2019s disease. Semin Cell Dev Biol. 2023;139:13\u201323. https:\/\/doi.org\/10.1016\/j.semcdb.2022.05.028","journal-title":"Semin Cell Dev Biol"},{"key":"3373_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"3373_CR17","doi-asserted-by":"publisher","first-page":"9143","DOI":"10.1021\/bi00102a004","volume":"30","author":"DA Snyder","year":"1991","unstructured":"Snyder DA, Rivers AM, Yokoe H, Menco BP, Anholt RR. Olfactomedin: purification, characterization, and localization of a novel olfactory glycoprotein. Biochemistry. 1991;30:9143\u201353. https:\/\/doi.org\/10.1021\/bi00102a004","journal-title":"Biochemistry"},{"key":"3373_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01596-0","volume":"11","author":"A Jernbom Falk","year":"2021","unstructured":"Jernbom Falk A, Galletly C, Just D, Toben C, Baune BT, Clark SR, et al. Autoantibody profiles associated with clinical features in psychotic disorders. Transl Psychiatry. 2021;11:474 https:\/\/doi.org\/10.1038\/s41398-021-01596-0","journal-title":"Transl Psychiatry"},{"key":"3373_CR19","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1523\/JNEUROSCI.0617-08.2008","volume":"28","author":"N Nakaya","year":"2008","unstructured":"Nakaya N, Lee HS, Takada Y, Tzchori I, Tomarev SI. Zebrafish olfactomedin 1 regulates retinal axon elongation in vivo and is a modulator of Wnt signaling pathway. J Neurosci. 2008;28:7900\u201310. https:\/\/doi.org\/10.1523\/JNEUROSCI.0617-08.2008","journal-title":"J Neurosci"},{"key":"3373_CR20","doi-asserted-by":"publisher","first-page":"180116","DOI":"10.1098\/rsob.180116","volume":"8","author":"CW He","year":"2018","unstructured":"He CW, Liao CP, Pan CL. Wnt signalling in the development of axon, dendrites and synapses. Open Biol. 2018;8:180116. https:\/\/doi.org\/10.1098\/rsob.180116","journal-title":"Open Biol"},{"key":"3373_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.arr.2008.11.003","volume":"8","author":"RA Boonen","year":"2009","unstructured":"Boonen RA, van Tijn P, Zivkovic D. Wnt signaling in Alzheimer\u2019s disease: up or down, that is the question. Ageing Res Rev. 2009;8:71\u201382. https:\/\/doi.org\/10.1016\/j.arr.2008.11.003","journal-title":"Ageing Res Rev"},{"key":"3373_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4","journal-title":"Mol Neurodegener"},{"key":"3373_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.expneurol.2013.09.019","volume":"250","author":"N Nakaya","year":"2013","unstructured":"Nakaya N, Sultana A, Munasinghe J, Cheng A, Mattson MP, Tomarev SI. Deletion in the N-terminal half of olfactomedin 1 modifies its interaction with synaptic proteins and causes brain dystrophy and abnormal behavior in mice. Exp Neurol. 2013;250:205\u201318. https:\/\/doi.org\/10.1016\/j.expneurol.2013.09.019","journal-title":"Exp Neurol"},{"key":"3373_CR24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1523\/JNEUROSCI.5154-06.2007","volume":"27","author":"A Cheng","year":"2007","unstructured":"Cheng A, Arumugam TV, Liu D, Khatri RG, Mustafa K, Kwak S, et al. Pancortin-2 interacts with WAVE1 and Bcl-xL in a mitochondria-associated protein complex that mediates ischemic neuronal death. J Neurosci. 2007;27:1519\u201328. https:\/\/doi.org\/10.1523\/JNEUROSCI.5154-06.2007","journal-title":"J Neurosci"},{"key":"3373_CR25","doi-asserted-by":"publisher","first-page":"e202201843","DOI":"10.26508\/lsa.202201843","volume":"6","author":"MG De Vas","year":"2023","unstructured":"De Vas MG, Boulet F, Joshi SS, Garstang MG, Khan TN, Atla G, et al. Regulatory de novo mutations underlying intellectual disability. Life Sci Alliance. 2023;6:e202201843. https:\/\/doi.org\/10.26508\/lsa.202201843","journal-title":"Life Sci Alliance"},{"key":"3373_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133. https:\/\/doi.org\/10.1126\/science.8346443","journal-title":"Science"},{"key":"3373_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1194\/jlr.R075481","volume":"58","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, Davis AA, Ulrich JD, Holtzman DM. Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-beta and other amyloidogenic proteins. J Lipid Res. 2017;58:824\u201336. https:\/\/doi.org\/10.1194\/jlr.R075481","journal-title":"J Lipid Res"},{"key":"3373_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","volume":"37","author":"JT Yu","year":"2014","unstructured":"Yu JT, Tan L, Hardy J. Apolipoprotein E in Alzheimer\u2019s disease: an update. Annu Rev Neurosci. 2014;37:79\u2013100. https:\/\/doi.org\/10.1146\/annurev-neuro-071013-014300","journal-title":"Annu Rev Neurosci"},{"key":"3373_CR29","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, et al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 2022;110:1304\u201317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","journal-title":"Neuron"},{"key":"3373_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","volume":"69","author":"XN Shen","year":"2023","unstructured":"Shen XN, Huang SY, Cui M, Zhao QH, Guo Y, Huang YY, et al. Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression. Clin Chem. 2023;69:411\u201321. https:\/\/doi.org\/10.1093\/clinchem\/hvad018","journal-title":"Clin Chem"},{"key":"3373_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","volume":"122","author":"Y Ji","year":"2003","unstructured":"Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients. Neuroscience. 2003;122:305\u201315. https:\/\/doi.org\/10.1016\/j.neuroscience.2003.08.007","journal-title":"Neuroscience"},{"key":"3373_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","volume":"17","author":"T Arendt","year":"1997","unstructured":"Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, et al. Plastic neuronal remodeling is impaired in patients with Alzheimer\u2019s disease carrying apolipoprotein epsilon 4 allele. J Neurosci. 1997;17:516\u201329. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-02-00516.1997","journal-title":"J Neurosci"},{"key":"3373_CR33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.neurobiolaging.2005.04.008","volume":"27","author":"S Love","year":"2006","unstructured":"Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging. 2006;27:797\u2013803. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.04.008","journal-title":"Neurobiol Aging"},{"key":"3373_CR34","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1074\/mcp.M115.056580","volume":"15","author":"RA Sweet","year":"2016","unstructured":"Sweet RA, MacDonald ML, Kirkwood CM, Ding Y, Schempf T, Jones-Laughner J, et al. Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease. Mol Cell Proteomics. 2016;15:2252\u201362. https:\/\/doi.org\/10.1074\/mcp.M115.056580","journal-title":"Mol Cell Proteomics"},{"key":"3373_CR35","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","volume":"112","author":"C Lopez-Lee","year":"2024","unstructured":"Lopez-Lee C, Torres ERS, Carling G, Gan L. Mechanisms of sex differences in Alzheimer\u2019s disease. Neuron. 2024;112:1208\u201321. https:\/\/doi.org\/10.1016\/j.neuron.2024.01.024","journal-title":"Neuron"},{"key":"3373_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jalz.2016.08.004","volume":"12","author":"HM Snyder","year":"2016","unstructured":"Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, et al. Sex biology contributions to vulnerability to Alzheimer\u2019s disease: a think tank convened by the women\u2019s Alzheimer\u2019s research initiative. Alzheimers Dement. 2016;12:1186\u201396. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.004","journal-title":"Alzheimers Dement"},{"key":"3373_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. a meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278:1349\u201356.","journal-title":"JAMA"},{"key":"3373_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11:393\u2013405. https:\/\/doi.org\/10.1038\/nrendo.2015.82","journal-title":"Nat Rev Endocrinol"},{"key":"3373_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2020.100879","volume":"60","author":"S Subramaniapillai","year":"2021","unstructured":"Subramaniapillai S, Almey A, Natasha Rajah M, Einstein G. Sex and gender differences in cognitive and brain reserve: Implications for Alzheimer\u2019s disease in women. Front Neuroendocrinol. 2021;60:100879 https:\/\/doi.org\/10.1016\/j.yfrne.2020.100879","journal-title":"Front Neuroendocrinol"},{"key":"3373_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jama.1994.03510370056032","volume":"271","author":"Y Stern","year":"1994","unstructured":"Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer\u2019s disease. JAMA. 1994;271:1004\u201310.","journal-title":"JAMA"},{"key":"3373_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/psyg.12552","volume":"20","author":"F Yasuno","year":"2020","unstructured":"Yasuno F, Minami H, Hattori H, Alzheimer\u2019s Disease Neuroimaging I. Interaction effect of Alzheimer\u2019s disease pathology and education, occupation, and socioeconomic status as a proxy for cognitive reserve on cognitive performance: in vivo positron emission tomography study. Psychogeriatrics. 2020;20:585\u201393. https:\/\/doi.org\/10.1111\/psyg.12552","journal-title":"Psychogeriatrics"},{"key":"3373_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/clinchem\/hvaa269","volume":"67","author":"LT Nordestgaard","year":"2021","unstructured":"Nordestgaard LT, Christoffersen M, Afzal S, Nordestgaard BG, Tybjaerg-Hansen A, Frikke-Schmidt R. Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: a study of 125 727 individuals. Clin Chem. 2021;67:245\u201355. https:\/\/doi.org\/10.1093\/clinchem\/hvaa269","journal-title":"Clin Chem"},{"key":"3373_CR43","doi-asserted-by":"publisher","first-page":"M712","DOI":"10.1093\/gerona\/57.11.m712","volume":"57","author":"G Atzmon","year":"2002","unstructured":"Atzmon G, Gabriely I, Greiner W, Davidson D, Schechter C, Barzilai N. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci. 2002;57:M712\u20135. https:\/\/doi.org\/10.1093\/gerona\/57.11.m712","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3373_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/00207454.2016.1182527","volume":"127","author":"KA Bates","year":"2017","unstructured":"Bates KA, Sohrabi HR, Rainey-Smith SR, Weinborn M, Bucks RS, Rodrigues M, et al. Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women. Int J Neurosci. 2017;127:243\u201352. https:\/\/doi.org\/10.1080\/00207454.2016.1182527","journal-title":"Int J Neurosci"},{"key":"3373_CR45","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","volume":"67","author":"C Reitz","year":"2010","unstructured":"Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol. 2010;67:1491\u20137. https:\/\/doi.org\/10.1001\/archneurol.2010.297","journal-title":"Arch Neurol"},{"key":"3373_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB Jr., Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13:48\u201360. https:\/\/doi.org\/10.1038\/nrcardio.2015.124","journal-title":"Nat Rev Cardiol"},{"key":"3373_CR47","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/nu9070725","volume":"9","author":"F Ma","year":"2017","unstructured":"Ma F, Wu T, Zhao J, Ji L, Song A, Zhang M, et al. Plasma homocysteine and serum folate and vitamin B(12) levels in mild cognitive impairment and Alzheimer\u2019s disease: a case-control study. Nutrients. 2017;9:725. https:\/\/doi.org\/10.3390\/nu9070725","journal-title":"Nutrients"},{"key":"3373_CR48","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1176\/appi.ajp.157.5.715","volume":"157","author":"BW Penninx","year":"2000","unstructured":"Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the women\u2019s health and aging study. Am J Psychiatry. 2000;157:715\u201321. https:\/\/doi.org\/10.1176\/appi.ajp.157.5.715","journal-title":"Am J Psychiatry"},{"key":"3373_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0010-440x(97)90925-1","volume":"38","author":"BR Hutto","year":"1997","unstructured":"Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry. 1997;38:305\u201314. https:\/\/doi.org\/10.1016\/s0010-440x(97)90925-1","journal-title":"Compr Psychiatry"},{"key":"3373_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1471-4159.2001.00384.x","volume":"78","author":"PI Ho","year":"2001","unstructured":"Ho PI, Collins SC, Dhitavat S, Ortiz D, Ashline D, Rogers E, et al. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem. 2001;78:249\u201353. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00384.x","journal-title":"J Neurochem"},{"key":"3373_CR51","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajpath.2017.08.032","volume":"188","author":"W Chan","year":"2018","unstructured":"Chan W, Almasieh M, Catrinescu MM, Levin LA. Cobalamin-associated superoxide scavenging in neuronal cells is a potential mechanism for vitamin B(12)-deprivation optic neuropathy. Am J Pathol. 2018;188:160\u201372. https:\/\/doi.org\/10.1016\/j.ajpath.2017.08.032","journal-title":"Am J Pathol"},{"key":"3373_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcell.2016.00016","volume":"4","author":"V Karamshetty","year":"2016","unstructured":"Karamshetty V, Acharya JD, Ghaskadbi S, Goel P. Mathematical modeling of glutathione status in type 2 diabetics with vitamin B12 deficiency. Front Cell Dev Biol. 2016;4:16. https:\/\/doi.org\/10.3389\/fcell.2016.00016","journal-title":"Front Cell Dev Biol"},{"key":"3373_CR53","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.freeradbiomed.2011.05.034","volume":"51","author":"ES Moreira","year":"2011","unstructured":"Moreira ES, Brasch NE, Yun J. Vitamin B12 protects against superoxide-induced cell injury in human aortic endothelial cells. Free Radic Biol Med. 2011;51:876\u201383. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.05.034","journal-title":"Free Radic Biol Med"},{"key":"3373_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonzalez-Billault C, Maccioni RB. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp Cell Res. 2004;295:245\u201357. https:\/\/doi.org\/10.1016\/j.yexcr.2004.01.002","journal-title":"Exp Cell Res"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03373-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:23:30Z","timestamp":1745580210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03373-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3373"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03373-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary [Correlation of peripheral olfactomedin 1 with Alzheimer's disease and cognitive functions] was missing from this article and has now been uploaded.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"146"}}